Sort
141,003 grants matching “cytokine”
Targeting STAT3 to enhance anti-tumor immunity
$636,402Daniel E Johnson · University Of California, San Francisco · R01 · FY2020 · DE
Targeting STAT3 to enhance anti-tumor immunity
$636,402Daniel E Johnson · University Of California, San Francisco · R01 · FY2023 · DE
Targeting STAT3 to enhance anti-tumor immunity
$636,402Daniel E Johnson · University Of California, San Francisco · R01 · FY2021 · DE
Immuno-Genetic Epidemiology of Complex Malaria in India
$636,399Matthew Thomas · New York University · U19 · FY2015 · AI
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment
$636,398Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · HL
PediAtric ReseArch of Drugs, Immunoparalysis and Genetics during MODS (PARADIGM)
$636,392Mark W Hall · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · HD
Heterogeneity of Satellite Cell Populations Play a Role in Improvements in PAD after Exercise Therapy
$636,387Laura Marie Hansen · Emory University · R01 · FY2024 · HL
Image-guided cancer therapy using heat activatable CAR T cells
$636,385Stanislav Y Emelianov · Georgia Institute Of Technology · R01 · FY2025 · EB
Long-Term CNS Consequences of Treatment During Acute Infection
$636,382Victor Valcour · University Of California, San Francisco · R01 · FY2011 · MH
SIV Cardiomyopathy: Pathogenesis and Prevention
$636,378Richard P Shannon · Harvard Medical School · R01 · FY2006 · HL
Anticoagulant and fibrinolytic therapies for toxic inhaled chemical
$636,378Carl W White · University Of Colorado Denver · U54 · FY2014 · ES
Adaptive and maladaptive repair after kidney injury
$636,329Katalin Susztak · University Of Pennsylvania · R01 · FY2024 · DK
Multi-Antigen Vaccines for the Primary and Secondary Prevention of Bladder CancerTO POP: 9/15/2017 - 3/14/2019
$636,313Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2017 · CA
Efficacy of Aspirin & Naproxen in Colorectal Cancer Models
$636,282Terisa Davis · · N01 · FY2013 · CA
The role of CMV secretome in the acceleration of transplant vascular sclerosis
$636,275Jay A Nelson · Oregon Health & Science University · R01 · FY2012 · HL
Development of P2Y Receptor Ligands
$636,265Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Genetic Modulation of Sickle Cell Anemia
$636,222Boston University Medical Campus · R01 · FY2001 · HL
Deciphering Disc Degeneration: Untangling the Roles of Age and Inflammation
$636,198Chun-Yuh Huang · University Of Miami Coral Gables · R01 · FY2025 · AR
Dynamic Neuroimmune Profiling in Patients with Acute Intracerebral Hemorrhage
$636,165Lauren H Sansing · Yale University · R01 · FY2016 · NS
Ultrasensitive kinase biosensors for multiplex imaging of coordinated spatiotemporal signaling in cancer-immune interactions
$636,160Jin Zhang · University Of California, San Diego · R01 · FY2023 · CA
Ubiquitin pathway inhibitors for treatment of asthma
$636,155Kumar Suresh · Progenra, Inc. · R44 · FY2018 · AI
Effect of breast feeding on immunologic priming in young infants.
$636,143John W Sleasman · Duke University · R01 · FY2015 · AI
Development of first-in-class ST2 inhibitors for treating graft-versus-host disease
$636,111Chao-Yie Yang · University Of Tennessee Health Sci Ctr · R01 · FY2021 · HL
The impact of inflammation on HSPC composition and disease progression in chronic myelomonocytic leukemia
$636,099Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Molecular Genetic Analysis Of Lymphocyte Function
$636,096David Margulies · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI